Abstract:Background: Vitiligo is characterized by the death of melanocytes in the skin.This is associated with the presence of T cell infiltrates in the lesional borders.However, at present, there is no detailed and systematic characterization on whether additional cellular or molecular changes are present inside vitiligo lesions.Further, it is unknown if the normal appearing non-lesional skin of vitiligo patients is in fact normal.The purpose of this study is to systematically characterize the molecular and cellular characteristics of the lesional and non-lesional skin of vitiligo patients.Methods and Materials: Paired lesional and non-lesional skin biopsies from twenty-three vitiligo patients and normal skin biopsies from sixteen healthy volunteers were obtained with informed consent.The following aspects were analyzed: (1) transcriptome changes present in vitiligo skin using DNA microarrays and qRT-PCR; (2) abnormal cellular infiltrates in vitiligo skin explant cultures using flow cytometry; and (3) distribution of the abnormal cellular infiltrates in vitiligo skin using immunofluorescence microscopy.Results: Compared with normal skin, vitiligo lesional skin contained 17 genes (mostly melanocyte-specific genes) whose expression was decreased or absent.In contrast, the relative expression of 13 genes was up-regulated.The up-regulated genes point to aberrant activity of the innate immune system, especially natural killer cells in vitiligo.Strikingly, the markers of heightened innate immune responses were also found to be up-regulated in the non-lesional skin of vitiligo patients. Conclusions and Clinical Implications:As the first systematic transcriptome characterization of the skin in vitiligo patients, this study revealed previously unknown molecular markers that strongly suggest aberrant innate immune activation in the microenvironment of vitiligo skin.Since these changes involve both lesional and non-lesional skin, our results suggest that therapies targeting the entire skin surface may improve treatment outcomes.Finally, this study revealed novel mediators that may facilitate future development of vitiligo therapies.

Disturbed expression of vitamin D and retinoic acid‐related orphan receptors α and γ and of megalin in inflammatory skin diseases

Impaired Nuclear Translocation of Glucocorticoid Receptors: Novel Findings from Psoriatic Epidermal Keratinocytes

Vitamin D Signaling in Psoriasis: Pathogenesis and Therapy

The Role of VD/VDR Signaling Pathway in Autoimmune Skin Diseases

Differential expression of phosphorylated extracellular signal-regulated kinase 1/2, phosphorylated p38 mitogen-activated protein kinase and nuclear factor-κB p105/p50 in chronic inflammatory skin diseases

Toll-like Receptors and Antimicrobial Peptides Expressions of Psoriasis: Correlation with Serum Vitamin D Level

OAS1, OAS2, and OAS3 Contribute to Epidermal Keratinocyte Proliferation by Regulating Cell Cycle and Augmenting IFN-1‒Induced Jak1‒Signal Transducer and Activator of Transcription 1 Phosphorylation in Psoriasis.

Skin microdialysis detects distinct immunological patterns in chronic inflammatory skin diseases

The Essential Role of microRNAs in Inflammatory and Autoimmune Skin Diseases—A Review

Vitamin D and the Pathophysiology of Inflammatory Skin Diseases

Bioactive Dietary VDR Ligands Regulate Genes Encoding Biomarkers of Skin Repair That Are Associated with Risk for Psoriasis

IRAK2 Has a Critical Role in Promoting Feed-Forward Amplification of Epidermal Inflammatory Responses

VDR Gene Polymorphisms Are Associated with the Clinical Response to Calcipotriol in Psoriatic Patients

Vitamin D receptor ablation alters skin architecture and homeostasis of dendritic epidermal T cells

LGR4 Deficiency Aggravates Skin Inflammation and Epidermal Hyperplasia in Imiquimod-Induced Psoriasis.

An important role of the SDF-1/CXCR4 axis in chronic skin inflammation

Deficiency of vitamin D receptor in keratinocytes augments dermal fibrosis and inflammation in a mouse model of HOCl-induced scleroderma

Transcriptome Analysis Reveals Markers of Aberrantly Activated Innate Immunity in Vitiligo Lesional and Non-Lesional Skin

Lipid Alterations and Metabolism Disturbances in Selected Inflammatory Skin Diseases

Reactive oxygen species produced by myeloid cells in psoriasis as a potential biofactor contributing to the development of vascular inflammation

LIGHT signaling through LTβR and HVEM in keratinocytes promotes psoriasis and atopic dermatitis-like skin inflammation